Risk association between human leukocyte antigen-A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women

Journal of Infectious Diseases

Volumn 192, Issue 10, 2005, Pages 1749-1756

  Chan, Denise P C ^a   Cheung, Tak Hong ^a   Tam, Ann O Y ^a   Cheung, Jo L K ^a   Yim, So Fan ^a   Lo, Keith W K ^a   Siu, Nelson S S ^a   Zhou, Daniel X ^a   Chan, Paul K S ^a,b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HLA A ANTIGEN; VIRUS DNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHINESE; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HLA TYPING; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; FEMALE; HLA-A ANTIGENS; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 27744561363     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/497342     Document Type: Article

References (28)

1. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003; 9:348-59.
2. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. J Natl Cancer Inst 1999; 91:506-11.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
4. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32(Suppl 1):S16-24.
5. Brestovac B, Harnett GB, Smith DW, Shellam GR, Frost FA. Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. J Med Virol 2005; 76:106-10.
6. Chan PK, Mak KH, Cheung JL, et al. Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J Med Virol 2002; 68:273-7.
7. Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002; 185:28-35.
8. Chan PK, Li WH, Chan MY, Ma WL, Cheung JL, Cheng AF. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 1999; 59:232-8.
9. Chan PK, Cheung TH, Tam AO, et al. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer (in press).
10. Villa LL. Human papillomaviruses and cervical cancer. Adv Cancer Res 1997; 71:321-41.
11. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415-23.
12. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000; 9:1183-91.
13. Ghaderi M, Wallin KL, Wiklund F, et al. Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes. Int J Cancer 2002; 100:698-701.
14. Dao DD, Sierra-Torres CH, Robazetti SC, et al. HLA-DQB1 and cervical cancer in Venezuelan women. Gynecol Oncol 2005; 96:349-54.
15. Hildesheim A, Schiffman M, Scott DR, et al. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 1998; 7:1035-41.
16. Montoya L, Saiz I, Rey G, Vela F, Clerici-Larradet N. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet 1998; 25:329-37.
17. Madeleine MM, Brumback B, Cushing-Haugen KL, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 2002; 186:1565-74.
18. Middleton D, Hawkins BR, Williams F, et al. HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing. Tissue Antigens 2004; 63:555-61.
19. Hurley CK. Sequence-based typing for HLA-A: class I sequencing amplification of exons 2 and 3 based upon cereb. In: Tilanus MGJ, ed. IHWG Manual 2003. Seattle WA: International Histocompatibility Working Group Press, 2003:7-A.
20. Anthony Nolan Trust. HLA-A sequence data. Available at: http://www .anthony.nolan.org.uk/HIG/seq/hlaa.html. Accessed 7 April 2005.
21. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310:170.
22. Chen S, Tabrizi SN, O'Sullivan H, Fairley CK, Quinn MA, Garland SM. Lack of association between HLA DQB1 alleles with HPV infection and histology findings in cervical cancer in Australian women. Int J Gynecol Cancer 1999; 9:220-4.
23. Odunsi K, Ganesan T. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis. Int J Mol Med 2001; 8:405-12.
24. Lin P, Koutsky LA, Critchlow CW, et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 2001; 10:1037-45.
25. Wang SS, Hildesheim A, Gao X, et al. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 2002; 186:598-605.
26. Carrington M, Wang S, Martin MP, et al. Hierarchy of resistance of cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 2005; 201:1069-75.
27. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002; 89:229-40.
28. Middleton D. Allele frequencies in worldwide populations. Available at: http://www.allelefrequencies.net. Accessed 6 June 2005.